TITLE

Can herbal medicines do lead to ovarian hyper stimulation syndrome? A retrospective cohort study

AUTHOR(S)
Hosseinpoor, M.; Rasekh Jahromi, A.; Alipour, F.
PUB. DATE
June 2014
SOURCE
Iranian Journal of Reproductive Medicine;Jun2014 Supplement, Vol. 12, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
Introduction: Ovarian hyper stimulation syndrome (OHSS) is an iatrogenic complication that occurs in the luteal phase of an induced hormonal cycle. It is supposed to be a complication of some medications. We aimed to assess the association between herbal medication and OHSS. Materials and Methods: A cohort of 120 married women diagnosed with OHSS participated in this retrospective study from 2011-2013. Among them, 86 cases had history of taking herbal medicine. Vaginal ultrasonography was performed in a Gynecology and Obstetrics Clinic in Jahrom University of Medical Sciences. List of herbs consumed was recorded and data analyzed by SPSS. Results: The participants were aged between 18-51 years (mean: 31). 54% of cases didn't have history of infertility, 36.5% were diagnosed with primary infertility and 9.5% with secondary infertility. 56% of OHSS women having history of taking nigrum (pepper), 30.2% of them used zingiber officinate (ginger), 25.6% used cinnamomum verum (Cinnamon), 19.8% of the cases consumed thymus vulgaris (Thyme), 15.1% of them used carum carvi (cumin) matricaria recutita (Chamomile), 14% of them used thum graveolensdhi (dill) and 14% of them used corocussativus (saffron). Consumption period was from third to eighth day of menstrual cycle for 1-4 months. Dosage of herbal regimes was one tablespoon (3g). The results showed that 100 (93.02%) individuals had mild OHSS, 17 (5.8%) had moderate OHSS and only 3 (1.1%) cases showed severe OHSS. Conclusion: We concluded that the indiscriminate use of herb might lead to OHSS. As the patients tend to consume herbs a lot, we hope to obtain the appropriate dosages of herb and use it as substitute of synthetic drugs with high side effects.
ACCESSION #
96841475

 

Related Articles

  • Does freeze all policy eliminate OHSS??? 'It ain't necessarily so...'. Blumenfeld, Zeev // Journal of Assisted Reproduction & Genetics;Oct2015, Vol. 32 Issue 10, p1571 

    No abstract available.

  • The eradication of ovarian hyperstimulation syndrome? Cheng, L. C.; Chia, C. M. // Reproductive BioMedicine Online (Reproductive Healthcare Limited;May2008 Supplement 2, Vol. 16 Issue S2, pS-21 

    Introduction: Ovarian hyperstimulation syndrome (OHSS) remains the most serious complication affecting women undergoing IVF. All existing protocols that use human chorionic gonadotrophin (HCG) to trigger final oocyte maturation are associated with a risk of OHSS. The only protocol that has been...

  • Combination of early oestradiol concentrations and oocyte number as a strong prognostic tool for ovarian hyperstimulation syndrome in IVF. Mittal, S.; Majumdar, A.; Gaur, R.; Majumdar, G. // Reproductive BioMedicine Online (Reproductive Healthcare Limited;May2008 Supplement 2, Vol. 16 Issue S2, pS-26 

    Introduction: Ovarian hyperstimulation syndrome (OHSS) is a potentially life-threatening and iatrogenic complication of ovarian stimulation. The key to controlling the syndrome is in its prevention and hence it is imperative to make an early prediction so that suitable measures can be taken to...

  • Principles of Diagnosis and Management in the Ovarian Hyperstimulation Syndrome. ONOFRIESCU, ALINA; LUCA, A.; BORS, A.; HOLICOV, M.; ONOFRIESCU, M.; VULPOI, CARMEN // Current Health Sciences Journal;Jul-Sep2013, Vol. 39 Issue 3, p187 

    Ovarian hyperstimulation syndrome (OHSS) is the most serious consequence of ovulation induction and in vitro fertilisation (IVF), potentially resulting in death in its extreme manifestation. How best to manage this condition has been the subject of considerable study, with primary emphasis on...

  • HCG (1500IU) administration on day 3 after oocytes retrieval, following GnRH-agonist trigger for final follicular maturation, results in high sufficient mid luteal progesterone levels - a proof of concept. Haas, Jigal; Kedem, Alon; Machtinger, Ronit; Dar, Shir; Hourvitz, Ariel; Yerushalmi, Gil; Orvieto, Raoul // Journal of Ovarian Research;2014, Vol. 7 Issue 1, p1 

    Background Controlled ovarian hyperstimulation (COH) which combining GnRH antagonist co-treatment and GnRH agonist trigger with an additional 1500 IU hCG luteal rescue on day of oocytes retrieval, has become a common tool aiming to reduce severe ovarian hyperstimulation syndrome (OHSS). In the...

  • Use of GnRH Agonist for Ovulation Trigger is Efficacious. Imbar, Tal // Fertility Weekly;7/23/2012, p7 

    The article presents a study concerning prevention of ovarian hyperstimulation syndrome (OHSS) in high risk patients. According to researchers in Israel, GnRH agonist (GnRHa) has triggered and intensive luteal phase support may prevent ovarian hyperstimulation syndrome (OHSS) among high risk...

  • A severe case of ovarian hyperstimulation syndrome with pulmonary thromboembolism. Arikan, Ilker; Barut, Aykut; Harma, Muge; Harma, Mehmet Ibrahim // Internet Journal of Gynecology & Obstetrics;2010, Vol. 13 Issue 1, p6 

    Ovarian hyperstimulation syndrome (OHSS) is an iatrogenic, life-threatening complication of ovarian stimulation. Renal and hepatic dysfunction, thrombosis, pulmonary edema, cerebral infarcts and adult respiratory distress syndrome are the leading causes of morbidity and mortality seen in severe...

  • POLAR BODY BIOPSY FOR CURSCHMANN-STEINERT DISEASE AND SUCCESSFUL PREGNANCY FOLLOWING EMBRYO VITRIFICATION. Macas, Ervin // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Jun2010 S2 Supplement, Vol. 20, pS48 

    Aim: The purpose of this study was to describe conditions that led to establishment of a viable pregnancy and delivery of an unaffected child in a women with Curschmann-Steinert disease after polar body diagnosis and vitrification of cleavage-stage embryos. Method: The simultaneous removal of...

  • Low follicular fluid tyrosine concentration in infertile women with ovarian hyperstimulation syndrome. NAMIKO AMANO; KOTARO KITAYA; SAGIRI TAGUCHI; MIYAKO FUNABIKI; YOSHIHIRO TADA; TERUMI HAYASHI; YOSHITAKA NAKAMURA // Biomedical Reports;2014, Vol. 2 Issue 3, p429 

    The aim of this study was to compare the branched-chain amino acid (BCAA) and tyrosine concentration in the follicular fluid of infertile women with and without ovarian hyperstimulation syndrome (OHSS) in an in vitro fertilization program combined with controlled ovarian stimulation. Follicular...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics